Skip to content
Review Open access

Long-Term Prenatal Systemic Glucocorticoid Exposure and Offspring Neurodevelopmental and Neuropsychiatric Outcomes: A Systematic Review.

Sep 2026 · Acta paediatrica · 0 citations · 38 references
Medicine

TL;DR

Prenatal glucocorticoid use was associated with modestly increased risks of ASD and ADHD, however, residual confounding by maternal disease severity remained a major limitation and a specific medication-related effect could not be conclusively established.

Abstract

Aim

A systematic review was conducted to clarify the association between long-term prenatal systemic glucocorticoid use of at least 7 days and offspring neurodevelopmental and neuropsychiatric outcomes.

Methods

PubMed, Embase, Web of Science, the Cumulative Index to Nursing and Allied Health Literature, Cochrane Library and PsycINFO were searched from inception to March 8, 2026. We identified four observational studies that evaluated prenatal systemic glucocorticoid exposure and offspring neurodevelopmental outcomes, including autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD) and intellectual disability (ID). Study quality was assessed, and a narrative synthesis was performed.

Results

Three nationwide cohorts (covering more than 1.2 million pregnancies) reported significantly elevated risks of ASD and ADHD following prenatal glucocorticoid exposure (adjusted risk ratio 1.3-1.5). The association with ID was inconsistent and non-significant (risk ratio 1.1-1.4). A single-centre study of 74 subjects did not find any significant cognitive differences.

Conclusion

Prenatal glucocorticoid use was associated with modestly increased risks of ASD and ADHD. However, residual confounding by maternal disease severity remained a major limitation and a specific medication-related effect could not be conclusively established. Glucocorticoid use should focus on the lowest dose and shortest duration, with clear counselling. Further research is required. TRIAL REGISTRATION International Prospective Register of Systematic Reviews: CRD420261327850.

Read PDF

Similar papers

Open access Sep 2026

Prenatal exposure to maternal depression and antidepressants and neurodevelopmental outcomes: A population cohort study

Background The long-term effects of antidepressant use in pregnancy on child neurodevelopment are unclear; meanwhile antidepressant use in pregnancy is increasing. We aimed to clarify associations between prenatal maternal depression and/or antidepressant exposure and neurodevelopmental outcomes in school-age children....

Saraid McIlvride, Ne-Ha Rao, Sarjit Singh et al. · 0 citations
Review Open access Aug 2026

Risk of schizophrenia in the offspring of mothers with diabetes during pregnancy: systematic review and meta-analysis.

Although maternal hyperglycemia may influence fetal neurodevelopment through inflammatory and metabolic mechanisms, the observational nature and limited number of included studies preclude causal inference, and these findings should be interpreted with caution.

Marianna Zanette Molha, Ana Julia de Magalhães Pina, Beatriz Yukie Filosi et al. · 0 citations
Review Open access Sep 2026

Maternal diabetes as a prenatal risk factor for multiple sclerosis in offspring: a systematic review and meta-analysis

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system with a complex etiology involving genetic and environmental factors. Maternal diabetes during pregnancy has been hypothesized to influence offspring MS risk through intrauterine metabolic programming, yet the evidence remains incon...

Mehdi Mohammadifar, Mahyar Ghajarzdaeh, M. Ghajarzadeh · 0 citations
Sep 2026

Paternal Valproate Exposure and Offspring Neurodevelopmental Outcomes.

A large population-based study in Asia found no increased risk of NDDs in offspring following paternal exposure to valproate or other ASMs, which may contribute to ongoing debates about the management of valproate in men of reproductive age.

Y. A. Feng, Mei-Chen Lin, Ching-Hsuan Tseng et al. · 0 citations
Oct 2026

Maternal COVID-19 During Pregnancy and Offspring Neurodevelopmental Disorders: A Nationwide Birth Cohort Study.

BACKGROUND Maternal coronavirus disease 2019 (COVID-19) during pregnancy was common during the pandemic. However, its potential risks for clinically diagnosed neurodevelopmental disorders in offspring, including attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD) and intellectual disability...

Y. Okubo, Kazuhiro Uda · 0 citations
Meta-analysis Open access Sep 2026

Long-term metabolic consequences of in-utero gestational diabetes exposure and maternal treatment interventions: a systematic review and meta-analysis

Background Gestational diabetes mellitus (GDM) affects 14–17% of pregnancies globally, imposing long-term public health burdens beyond pregnancy. Maternal hyperglycaemia increases offspring risk of metabolic disorders through epigenetic, hormonal and developmental programming. Growing evidence connects prenatal GDM exp...

Yu-Feng Wu, Ke Shen, Hui-Hui Guo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.